14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 7th May 2024 MGNX stock ended at $16.05. This is 1.95% less than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 4.80% from a day low at $15.62 to a day high of $16.37.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical MacroGenics prices

Date Open High Low Close Volume
Jul 01, 2016 $26.89 $27.52 $26.59 $27.19 305 400
Jun 30, 2016 $26.95 $27.57 $26.34 $26.99 567 200
Jun 29, 2016 $26.46 $27.24 $25.64 $26.91 330 600
Jun 28, 2016 $23.67 $27.00 $23.53 $25.86 422 500
Jun 27, 2016 $23.99 $24.91 $22.39 $23.05 356 700
Jun 24, 2016 $24.80 $25.60 $24.07 $24.13 346 700
Jun 23, 2016 $24.79 $26.55 $24.41 $26.39 296 100
Jun 22, 2016 $24.27 $25.90 $23.92 $24.39 203 900
Jun 21, 2016 $24.64 $24.72 $23.57 $24.29 192 300
Jun 20, 2016 $24.85 $25.01 $24.03 $24.54 247 600
Jun 17, 2016 $25.55 $25.74 $24.03 $24.35 539 300
Jun 16, 2016 $25.37 $25.60 $24.78 $25.48 258 590
Jun 15, 2016 $25.58 $26.22 $25.03 $25.58 297 560
Jun 14, 2016 $26.31 $26.78 $24.91 $25.31 302 733
Jun 13, 2016 $25.84 $26.83 $25.67 $26.36 365 552
Jun 10, 2016 $26.83 $26.93 $25.99 $26.16 222 704
Jun 09, 2016 $27.18 $27.51 $26.86 $27.28 291 364
Jun 08, 2016 $27.95 $28.09 $27.17 $27.50 223 275
Jun 07, 2016 $27.91 $28.33 $27.43 $27.85 275 492
Jun 06, 2016 $26.47 $28.37 $25.96 $28.20 285 419
Jun 03, 2016 $27.30 $27.30 $26.16 $26.38 305 362
Jun 02, 2016 $25.88 $27.47 $25.73 $27.44 261 482
Jun 01, 2016 $25.44 $26.39 $25.12 $25.94 241 231
May 31, 2016 $24.75 $25.90 $24.61 $25.56 278 580
May 27, 2016 $23.97 $25.30 $23.81 $24.50 233 197
Click to get the best stock tips daily for free!

About MacroGenics

MacroGenics MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The... MGNX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT